Microbially produced glucagon-like peptide 1 improves glucose tolerance in mice
Objective: The enteroendocrine hormone glucagon-like peptide 1 (GLP-1) is an attractive anti-diabetic therapy. Here, we generated a recombinant Lactococcus lactis strain genetically modified to produce GLP-1 and investigated its ability to improve glucose tolerance in mice on chow or high-fat diet (...
Saved in:
Main Authors: | Tulika Arora (Author), Udo Wegmann (Author), Anup Bobhate (Author), Ying Shiuan Lee (Author), Thomas U. Greiner (Author), Daniel J. Drucker (Author), Arjan Narbad (Author), Fredrik Bäckhed (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insulin-like peptide 5 is a microbially regulated peptide that promotes hepatic glucose production
by: Ying Shiuan Lee, et al.
Published: (2016) -
Microbial regulation of GLP-1 and L-cell biology
by: Thomas U. Greiner, et al.
Published: (2016) -
Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
by: Laurie L. Baggio, et al.
Published: (2021) -
Genome-wide association study of circulating levels of glucagon during an oral glucose tolerance test
by: Anna Jonsson, et al.
Published: (2021) -
Glucagon-like peptide 1 (GLP-1)
by: T.D. Müller, et al.
Published: (2019)